Clinical Trials Logo

Filter by:
NCT ID: NCT06136169 Not yet recruiting - Clinical trials for Homonymous Hemianopia

Reminder-cue Scanning Training for Homonymous Visual Field Loss

Start date: May 2024
Phase: N/A
Study type: Interventional

This study will evaluate a new approach to training people with visual field loss to scan when driving

NCT ID: NCT06136156 Recruiting - Clinical trials for Adults 18 Years and Older (no Other Exclusion Criteria)

Video Vitals and Biomarkers

Start date: October 31, 2023
Phase:
Study type: Observational

The investigators are doing this research to study the ability of mobile devices to measure vital signs and biomarkers from video as compared to standard-of-care clinical office tools.

NCT ID: NCT06136104 Completed - Healthy Clinical Trials

The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess Mixhers HERTIME supplements efficacy in alleviating menstrual cycle symptoms.

NCT ID: NCT06136091 Recruiting - Asthma Clinical Trials

Protocol CAUSE-03 / CHEETAH

CHEETAH
Start date: April 23, 2024
Phase:
Study type: Observational

This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot have used asthma medications in the year prior to enrollment and cannot demonstrate bronchodilator reversibility at baseline. Phenotypic characteristics will be established at baseline, and the participants will be seen at scheduled visits over 12 months. Each participant will be asked to monitor and self-report cold symptoms and will be asked to complete up to three cold visits

NCT ID: NCT06136078 Recruiting - Clinical trials for Traumatic Intracranial Subarachnoid Hemorrhage

Appropriateness of Methodist Health System(MHS) Inter-facility Transfers of Traumatic Intracranial Subarachnoid Hemorrhage and Spontaneous Bleeds for Level-1 Advanced Surgical Intervention

Start date: June 20, 2022
Phase:
Study type: Observational

Brain injuries are common and challenging problems faced by emergency physicians. These diagnoses may include traumatic intracerebral hemorrhage, subarachnoid hemorrhage, ruptured cerebral aneurysms, unruptured cerebral aneurysms, and arteriovenous malformations, which require neurological, neurosurgical, and/or endovascular treatment.

NCT ID: NCT06135974 Recruiting - Bacterial Vaginosis Clinical Trials

Vaginal lIve Biotherapeutic RANdomized Trial

VIBRANT
Start date: October 19, 2023
Phase: Early Phase 1
Study type: Interventional

The goal of this randomized clinical trial is to evaluate safety and biologic effect of a multi-strain vaginal L. crispatus live biotherapeutic product (LBP) in people receiving antibiotic treatment for bacterial vaginosis (BV). The main question[s] it aims to answer are whether the intervention is safe, and whether the strains of L. crispatus will colonize recipients' vagina. The study will evaluate one LBP with 6 strains of L. crispatus (LC106) and one LBP with 15 strains (LC115) vs. placebo. Participants will: - be treated with oral antibiotics for BV - receive 7 days of vaginal study product - collect daily home swabs and make short daily diary entries for 5 weeks, including the week of antibiotic treatment and the week of study product treatment. Researchers will compare the 3 groups receiving different dosing strategies of LC106 and 1 group receiving LC115 vs. 1 group receiving placebo to see if the live biotherapeutic strains colonize the vagina after antibiotic treatment for BV.

NCT ID: NCT06135870 Recruiting - Leiomyoma Clinical Trials

Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

SOUL
Start date: November 1, 2023
Phase:
Study type: Observational

The investigators are evaluating the role of senescent cells in uterine fibroids.

NCT ID: NCT06135844 Recruiting - Virus Clinical Trials

Hand Sanitizer Use for Herpes Simplex Virus-1

Start date: April 8, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration of an HSV-1 (herpes) lesion is the primary endpoint for this study. Size, pain, and discomfort are the secondary endpoints.

NCT ID: NCT06135727 Enrolling by invitation - Glaucoma Clinical Trials

Screening Protocol

Start date: November 7, 2023
Phase: N/A
Study type: Interventional

The objective of this study is to collect data for the development and validation a screening process using aggregate data. In this study, data collection will encompass both retrospective and prospective approaches across multiple sites in the United States.

NCT ID: NCT06135610 Completed - COVID-19 Clinical Trials

Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic

Start date: March 1, 2019
Phase:
Study type: Observational

Investigators report on the impact of the COVID-19 stay-at-home order concerning penetrating violence and its association within different socioeconomic regions within the county. The distribution and volume of violent offenses prior to the stay-at-home order was compared to during the stay-at-home order. This bears a crucial significance in our injury prevention and education efforts within our community.